- active not recruitingPHASE2, PHASE3
A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
This study is testing a new medicine, linsitinib, for people with active, moderate to severe Thyroid Eye Disease (TED). Researchers want to see if it's safe and effective compared to a dummy pill over 24 weeks.
United States · Canada · Italy - authorisedPhase I and Phase II (Integrated)- Other
The use of [68Ga]Ga-FAPI PET/MRI in assessing disease activity in patients with Graves’ orbitopathy
This study is looking at a new type of body scan (PET/MRI) for people with Graves' orbitopathy. It wants to see if this scan can show how active the eye condition is. This could help doctors understand your condition better.
Netherlands